Number of Shares
905,000.00
Current Holdings Value*
$13.77 Mil
% of Portfolio
2.66%
Total Estimate Gain
$823,550.00
% of Total Estimate Gain
5.68%

Octagon Capital Advisors LP's Tourmaline Bio Inc Holding Summary

As of 2025-03-31, Octagon Capital Advisors LP held 905,000.00 shares of Tourmaline Bio Inc(TRML), totaling $13.77 Mil. This investment constitutes 2.66% of their stock portfolio, and Octagon Capital Advisors LP now holds 3.52% of the outstanding Tourmaline Bio Inc(TRML) stock.

The initial trade took place in 2025Q1. And since then Octagon Capital Advisors LP has made 1 purchases of TRML, at an average price of $16.03, for a total of 905,000.00 shares. Based on historical transaction data and TRML's current price of $16.94, Octagon Capital Advisors LP's estimated gain on his TRML holdings is $823,550.00, reflecting a 5.68% gain to date.

Octagon Capital Advisors LP TRML ($16.94) Holding Chart

Octagon Capital Advisors LP TRML ($16.94) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1